Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 20, 2018

New device to monitor foetal movements in high-risk pregnancies

Researchers at Imperial College London have developed a new sensor-based device to monitor foetal movements in high-risk pregnancies.

Researchers at Imperial College London have developed a new sensor-based device to monitor foetal movements in high-risk pregnancies.

The device enables physicians to monitor pregnancies where the baby is not growing as expected.

The system provides an alternative to the current self-reporting system, which requires mothers to notice changes in their baby’s movements and seek medical help. This approach is often inaccurate and may lead mothers to feel anxious or not report changes that should be recorded.

Imperial College London Department of Bioengineering Niamh Nowlan said: “The movements of a baby in the womb, foetal movements, are an important sign of the baby’s health. However, there is currently no way to monitor foetal movements outside of a hospital.”

“Foetal movements, are an important sign of the baby’s health.”

However, the new sensor can be worn for an extended duration and is designed to monitor the baby based on its movements and sound.

The research team is specifically focussed on the effect that foetal movements can have on skeletal development and associated disorders such as hip dysplasia. They embedded the system with accelerometers and acoustic sensors to facilitate differentiation between movements of the baby and mother.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Nowlan added: “Our device is the first to use acoustic sensors to detect movements. It is also unique in that it can account for movements of the mother, which other previously proposed sensors cannot.

“We believe that this is a key aspect of the technology that will lead to successful adoption in the clinic and home.”

While technical improvements are required to enhance the accuracy of the device, the team believes that it can be in widespread use within ten years.

Related Companies

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU